4 Results for "

SKMEL5

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SKMEL5" in MCE Product Catalog:

Cat. No.: HY-161886
CAS No.: 2270879-43-9
Target:  

SWI/SNF Complex

Research Areas:  

Cancer

SMARCA2-IN-7 (compound 12), a dual inhibitor of BRM and BRG1 (IC50 < 0.005 for both), has an anti-tumor proliferation effect that inhibits BRG1-deleted SKMEL5 tumor proliferation with a cell proliferation activity AAC50 of 13 nM in SKMEL5. The cell proliferation activity AAC50 of KRT880 in H1299 cells was 42 nM .
loading...
    loading...
Cat. No.: HY-161887
CAS No.: 2270875-93-7
Target:  

SWI/SNF Complex

Research Areas:  

Cancer

SMARCA2-IN-8 (Compound 13) is an orally active inhibitor for SWI/SNF chromatin remodeling complexe SMARCA2 (also known as Brahma homologue, BRM) and SMARCA4 (also known as Brahma-related gene 1, BRG1) with IC50 of 5 and 6 nM. SMARCA2-IN-8 inhibits the proliferation of SMARCA2 mutated cancer cell SKMEL5 with AAC50 of 5 nM. SMARCA2-IN-8 downregulates the SMARCA2-dependent KRT80 gene expression with AAC50 of 10 nM. SMARCA2-IN-8 exhibits antitumor efficacy and good pharmacokinetic characteristics in mice .
loading...
    loading...
Cat. No.: HY-151587
CAS No.: 2977251-05-9
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 89 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity, has high inhibition against the three cell line from ovarian cancer (OVCAR-4), renal cancer (A498), and melanoma (SK-MEL-5) .
loading...
    loading...
Cat. No.: HY-161885
CAS No.: 2270875-79-9
Target:  

SWI/SNF Complex

Research Areas:  

Cancer

SMARCA2-IN-6 is a SMARCA2 and SMARCA4 inhibitor, with an IC50 value of <0.005 μM for both SMARCA2 and SMARCA4. SMARCA2-IN-6 exerts anticancer activity against BRG1-mutant melanoma. SMARCA2-IN-6 can be used for research related to Brg1/Smarca4-mutant cancers .
loading...
    loading...